When patients find themselves interacting with information about their health and well-being, it is the responsibility of healthcare professionals to ensure that these interactions are as meaningful and productive as they can be. In this regard, the informed consent process is among the most important facets of clinical research currently undergoing a digital transformation, and pharmaceutical companies must continue to adopt eConsent across the board.
It’s been about a year since we released our first Focus 5 eBook on mHealth, and in that time much has changed in the digital health landscape. With a clearer understanding of the benefits, organizations are eager to integrate mobile health solutions to steamline patient care, and stengthen patient recruitment and engagement programs, while tech innovators continue to advance and refine these technologies for optimal clinical use. Now that mHealth has entered this next phase of adoption and development, it’s the perfect time to see where we are and where we still must go.